Economics of the Pharmaceutical Industry
From PHM Oz
(Difference between revisions)
DavidLegge (Talk | contribs) |
|||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
| − | |||
| − | Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs | + | High profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research |
| − | investment in drug development | + | |
| + | Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development | ||
Research often funded by public purse (universities) but profits go to industry. | Research often funded by public purse (universities) but profits go to industry. | ||
| − | [[Intellectual Property and Pharmaceuticals|Back to IP home]] | + | [[Intellectual Property and Pharmaceuticals|Back to IP home]]</br> |
| + | [[PHM_Oz_IP_Project|IP Project Page]] | ||
Latest revision as of 23:51, 10 July 2007
High profits justified in terms of generating funds for drug development but relatively low proportion of revenues going to research
Mal-distribution of research funds: more towards me-too drugs and less to Type III drugs investment in drug development
Research often funded by public purse (universities) but profits go to industry.
